Načítá se...

Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.

The effect of a cardioselective beta-adrenergic blocking agent, metoprolol, on symptoms and exercise tolerance was studied in 16 patients with angina pectoris. Metroprolol was compared with placebo at two dose levels (20 mg t.d.s. and 50 mg t.d.s.) in a double-blind trial in 14 patients. Compared wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ekelund, L G, Olsson, A G, Orö, L, Rössner, S
Médium: Artigo
Jazyk:Inglês
Vydáno: 1976
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC482986/
https://ncbi.nlm.nih.gov/pubmed/4080
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!